The Role of Kynurenine Pathway and NAD Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Dehhaghi M et al. (2022). The Role of Kynurenine Pathway […]
Research Papers
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.
Fluge O et al. (2016) Metabolic profiling indicates impaired pyruvate
Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.
Germain A et al. (2018) Metabolic profiling of a myalgic
Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology.
Germain A et al. (2018) Prospective Biomarkers from Plasma Metabolomics
Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids.
Germain A et al. (2020) Comprehensive Circulatory Metabolomics in ME/CFS
Plasma metabolomics reveals disrupted response and recovery following maximal exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Germain A et al. (2022) Plasma metabolomics reveals disrupted response
A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
Huth TK et al. (2020) A systematic review of metabolomic
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Apostolou E et al. (2022) Saliva antibody-fingerprint of reactivated latent
No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome.
No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Read More »
Burbelo PD et al. (2012) No serological evidence for a
Serological and virological investigation of the role of the herpesviruses EBV, CMV, HHV-6 in post-infective fatigue syndrome.
Cameron B et al. (2010) Serological and virological investigation of
Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Chapenko S et al . (2012) Association of active human
EBV/HHV-6A dUTPases contribute to Myalgic Encephalomyelitis/Chronic-Fatigue-Syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.
Cox BS et al. (2022) EBV/HHV-6A dUTPases contribute to Myalgic
Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.
Domingues TD et al. (2021) Herpesviruses Serology Distinguishes Different Subgroups
Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue.
Fevang B et al. (2021) Lasting Immunological Imprint of Primary
Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
Gravelsina S et al. (2022) Biomarkers in the diagnostic algorithm
Tissue specific signature of HHV-6 infection in ME/CFS.
Tissue specific signature of HHV-6 infection in ME/CFS. Read More »
Kasimir F, et al. (2022), Tissue specific signature of HHV-6
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
Kogelnik AM et al. (2006) Use of valganciclovir in patients
Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lee JS et al . (2021) Salivary DNA Loads for
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome.
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome. Read More »
Loebel M et al. (2014) Deficient EBV-Specific B- and T-Cell
A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV-6 and HHV-7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis.
Maltsev D (2022) A comparative study of valaciclovir, valganciclovir, and